Abstract
Oral verruciform xanthoma (OVX) is an uncommon lesion that appears on the oral mucosa. The aim of this paper was to discuss the probable etiopathogenesis of OVX in the hard palate, reinforcing the importance of including this lesion in the differential diagnosis of verrucous lesions. A 43-year-old male smoker presented with a painless lesion with a verrucous surface and erythematous spots on the hard palate. Excisional biopsy revealed oral mucosa consisting of hyperkeratosis, acanthosis, and elongated rete pegs. Subjacent connective tissue showed numerous foam cells with clear cytoplasm and pyknotic nucleus, negative on periodic acid-Schiff staining. Immunohistochemical analysis revealed foam cells positive for anti-CD68 antibody, while anti-KI-67 antibody was restricted to the basal layer of the oral epithelium. A final diagnosis of OVX was established. The patient showed no signs of recurrence after seven months of follow-up. Physical trauma and smoking habits can be directly related to the etiology of verruciform xanthoma because the lesion is chronic and inflammatory with slow growth, and sites if high trauma are more often affected by such a lesion. The hard palate is the second most commonly affected site, and local trauma caused by smoking can be a cause of this type of lesion.
Oral verruciform xanthoma (OVX) is an uncommon lesion described by Shafer in 19711, that appears on oral mucosa as a reactive lesion. The etiopathogenesis of this lesion remains unclear, with reaction response to trauma the most accepted explanation2. Contrary to skin xanthomas that are associated with metabolic disturbances of lipids, OVXs are not related to any generalized disease3.
This lesion may occur anywhere in the oral mucosa, but the hard palate is the second most commonly affected site, representing approximately 15% of all cases in a large survey4.
The treatment for OVX is surgical resection, and recurrence is extremely rare4. Interestingly, the three recurrence case reports in the English literature occurred in the hard palate567.
The aim of this paper was to discuss the probable etiopathogenesis of OVX in the hard palate, reinforcing the importance of including this benign lesion in the differential diagnosis of verrucous lesions in this location.
A 43-year-old man presented with a painless lesion in the hard palate, discovered during routine examination two months before. Clinically, a lesion with a verrucous surface and erythematous spots was observed next to the first upper right molar, measuring approximately 5 mm in diameter.(Fig. 1) The patient was a current smoker. The presumptive diagnosis was squamous cell carcinoma or traumatic ulcer. Excisional biopsy was performed, and the surgical specimen was sent to the Bauru School of Dentistry Oral Pathology Biopsy Service of the University of São Paulo (Bauru, Brazil). Histopathological examination revealed oral mucosa consisting of hyperkeratosis, acanthosis, and elongated rete pegs. Subjacent connective tissue showed numerous foam cells with clear cytoplasm and pyknotic nucleus, negative on periodic acid-Schiff staining.(Fig. 2. A, 2. B) Immunohistochemical analysis revealed that foam cells were positive for anti-CD68 antibody (Fig. 2. C), and anti-KI-67 antibody was restricted to the basal layer of the oral epithelium and negative for foam cells.(Fig. 2. D) Based on clinical and microscopic features, the final diagnosis of OVX was established. After seven months of follow-up, the patient showed no signs of recurrence.(Fig. 3)
OVX is an uncommon lesion that was first described by Shafer in 19711. It typically presents as a single lesion, the color of normal oral mucosa with verrucous surface, affecting mostly individuals over 40 years48. It can be confused clinically with verruca vulgaris, traumatic ulcers, and squamous cell carcinoma.
Histologically, it is characterized by hyperkeratosis, elongated rete pegs, and aggregates of foam cells in the submucosal stroma without epidermal atypia. Foam cells of verruciform xanthoma are of monocyte-macrophage lineage, based on intense cytoplasmic positivity for anti-CD68 and cathepsin B910.
The hard palate is the second most common area affected by OVX4. The relationship of this lesion with local trauma can explain why the gums and hard palate are impacted. The trauma induced by cigarettes in this location may also be involved in this lesion. Interestingly, the only three reports of recurrent OVX are in the hard palate567. This finding reinforces that areas experiencing excessive trauma are more affected by OVX.
OVX usually presents as a small solitary, sessile, or pedunculated lesion with a rough, slightly elevated surface and tends to be asymptomatic. The prevalence of OVX is unknown, although a relative frequency rate of 0.025% to 0.05% has been reported in the literature211. Such lesions occur most often on the gingiva, followed by hard palate, tongue, buccal mucosa, floor of the mouth, and soft palate4.
Philipsen et al.4 showed in a large survey that OVX are common in men below the age of 50 years. In the present case, the patient was a 43-year-old male smoker who presented with a 0.5 cm lesion in the hard palate of two months duration.
We found 12 studies in the literature reporting verruciform xanthoma in the hard palate6812131415161718192021. Articles without clinical information, immunohistochemical studies, multiple lesions, or involving the soft palate were excluded. The results are shown in Table 1.
Men were twice as likely to be affected than women (2:1). Lesions were normally small (average size of lesions 0.85 cm); however, three OVX lesions were 2 cm or more. The lesion surface was mostly verrucous. Older patients in the 40 to 90 year age range (mean age, 54 years) were significantly more frequently affected than younger patients. Almost 63% of the patients were smokers (5 of the 8 cases).
This case reinforces that OVX in the hard palate presents as small, painless lesions and affects men below 50 years. The influence of smoking habits is discussed below.
The diagnostic hallmark of OVX is the presence of lipidladen macrophages in the connective tissue between the epithelial ridges2416. An extensive immunohistochemical study showed that foam cells are of monocyte-macrophage lineage based on intense cytoplasmic positivity for anti-CD68 and cathepsin B9. Rawal et al.10 demonstrated that macrophages present in OVX are primarily reparative and resident, supporting the chronic reactive nature of OVX. In this case, a large number of xanthoma cells with clear cytoplasm and pyknotic nucleus were found. These cells were positive for CD6, confirming them as macrophages. The anti-KI-67 antibody was restricted to the basal layer of the epithelium, showing that the lesion was not malignant.
The pathogenesis of OVX remains unknown. Most patients with OVX do not have hyperlipidemia22. The mechanism of the accumulation of lipid-containing foam cells in the submucosa or dermis is also not clear2.
An ultrastructural and immunohistochemical study showed that, after the development of OVX, oxidized low-density lipoprotein (ox-LDL) induces foam cell necrosis, and resident macrophages clean the debris and cyclically perpetuate VX23. Ultrastructural and in situ hybridization have not shown an association between HPV and OVX, excluding a viral etiology for this lesion24.
Metabolic abnormalities of lipids and lymphedema are associated with nonmucosal cutaneous verruciform xanthoma325. The obstruction of lymphatic vessels results in accumulation of lipids in the connective tissue, and these lipids are scavenged by macrophages, producing xanthomas in patients with lymphedema25.
Patients with CHILD syndrome show inactivity of an enzyme related with cholesterol synthesis and interestingly have been reported to have concomitant verruciform xanthoma26.
The association of systemic diseases with cutaneous verruciform xanthoma but not OVX indicates that local trauma and inflammation are the most likely causes of OVX, since the epithelial cell degeneration caused by this condition releases lipid material that is scavenged by local macrophages. Studies have shown that the macrophages present in OVX are resident, mature, chronic inflammatory macrophages, confirming that is a chronic, slow-growing inflammatory lesion10.
These findings are consistent with the influence of smoking habits in the pathogenesis of OVX. Local trauma caused by cigarettes, especially in the hard palate, may be associated with OVX development. However, further studies need to be performed to confirm this association.
We did not find specific OVX surveys by location in the literature. The hard palate is the second most affected area, and local trauma caused by smoking can be a cause of this lesion. Knowledge of uncommon lesions in the mouth is extremely important for a correct diagnosis and treatment.
References
1. Shafer WG. Verruciform xanthoma. Oral Surg Oral Med Oral Pathol. 1971; 31:784–789. PMID: 5280461.
2. Hegde U, Doddawad VG, Sreeshyla H, Patil R. Verruciform xanthoma: a view on the concepts of its etiopathogenesis. J Oral Maxillofac Pathol. 2013; 17:392–396. PMID: 24574658.
3. Zegarelli DJ, Zegarelli-Schmidt EC, Zegarelli EV. Verruciform xanthoma. Further light and electron microscopic studies, with the addition of a third case. Oral Surg Oral Med Oral Pathol. 1975; 40:246–256. PMID: 1057149.
4. Philipsen HP, Reichart PA, Takata T, Ogawa I. Verruciform xanthoma--biological profile of 282 oral lesions based on a literature survey with nine new cases from Japan. Oral Oncol. 2003; 39:325–336. PMID: 12676251.
5. Iamaroon A, Vickers RA. Characterization of verruciform xanthoma by in situ hybridization and immunohistochemistry. J Oral Pathol Med. 1996; 25:395–400. PMID: 8890055.
6. Nowparast B, Howell FV, Rick GM. Verruciform xanthoma. A clinicopathologic review and report of fifty-four cases. Oral Surg Oral Med Oral Pathol. 1981; 51:619–625. PMID: 6942361.
7. Neville B. The verruciform xanthoma. A review and report of eight new cases. Am J Dermatopathol. 1986; 8:247–253. PMID: 3728885.
8. Kakarantza-Angelopoulou E, Nicolatou O, Anagnostopoulou S. Verruciform xanthoma of the palate: case report with electron microscopy. J Oral Maxillofac Surg. 1991; 49:409–412. PMID: 2005497.
9. Mostafa KA, Takata T, Ogawa I, Ijuhin N, Nikai H. Verruciform xanthoma of the oral mucosa: a clinicopathological study with immunohistochemical findings relating to pathogenesis. Virchows Arch A Pathol Anat Histopathol. 1993; 423:243–248. PMID: 8236821.
10. Rawal SY, Kalmar JR, Tatakis DN. Verruciform xanthoma: immunohistochemical characterization of xanthoma cell phenotypes. J Periodontol. 2007; 78:504–509. PMID: 17335374.
11. Buchner A, Hansen LS, Merrell PW. Verruciform xanthoma of the oral mucosa. Report of five cases and review of the literature. Arch Dermatol. 1981; 117:563–565. PMID: 7294847.
12. Hume WJ, Smith CJ, Franklin CD. Verruciform xanthoma. Br J Oral Surg. 1980; 18:157–161. PMID: 6934808.
13. Neville BW, Weathers DR. Verruciform xanthoma. Oral Surg Oral Med Oral Pathol. 1980; 49:429–434. PMID: 6154914.
14. Rhinow K, Kalz S, Gelderblom R, Reichart A. Verruciform xanthoma. Mund Kiefer Gesichtschir. 2003; 7:52–55. PMID: 12556987.
15. Hu JA, Li Y, Li S. Verruciform xanthoma of the oral cavity: clinicopathological study relating to pathogenesis. Report of three cases APMIS. 2005; 113:629–634. PMID: 16218939.
16. Yu CH, Tsai TC, Wang JT, Liu BY, Wang YP, Sun A, et al. Oral verruciform xanthoma: a clinicopathologic study of 15 cases. J Formos Med Assoc. 2007; 106:141–147. PMID: 17339158.
17. Cheng YS, Wright J, Lucente J, McQuade MJ. Oral and maxillofacial pathology case of the month. Verruciform xanthoma. Tex Dent J. 2010; 127:126–127. 130–131. PMID: 20162945.
18. Shahrabi Farahani S, Treister NS, Khan Z, Woo SB. Oral verruciform xanthoma associated with chronic graft-versus-host disease: a report of five cases and a review of the literature. Head Neck Pathol. 2011; 5:193–198. PMID: 21305367.
19. Ryu DJ, Lee SH, Yuk JI, Kim HJ, Huh JK, Park KH. Verruciform xanthoma of the palatal gingiva: a report of two cases. J Korean Assoc Oral Maxillofac Surg. 2013; 39:292–296. PMID: 24516820.
20. Aggarwal S, Aggarwal A, Gill S, Bakshi Y, Singh HP. Verruciform xanthoma of oral cavity- a case report. J Clin Diagn Res. 2014; 8:FD11–FD12.
21. Bhattacharyya I, Islam N. Diagnostic discussion. Verruciform xanthoma. Todays FDA. 2014; 26:49–51. PMID: 24988733.
22. Tang R, Kopp SA, Cobb C, Halpern AV. Disseminated verruciform xanthoma: a case report. Cutis. 2014; 93:307–310. PMID: 24999643.
23. Ide F, Obara K, Yamada H, Mishima K, Saito I, Kusama K. Cellular basis of verruciform xanthoma: immunohistochemical and ultrastructural characterization. Oral Dis. 2008; 14:150–157. PMID: 18302675.
24. Sah K, Kale AD, Hallikerimath S. Verruciform xanthoma: report of two cases and review on pathogenesis. J Oral Maxillofac Pathol. 2008; 12:41–44.
25. Snider RL. Verruciform xanthomas and lymphedema. J Am Acad Dermatol. 1992; 27:1021–1023. PMID: 1479086.
26. Bittar M, Happle R. CHILD syndrome avant la lettre. J Am Acad Dermatol. 2004; 50(2 Suppl):S34–S37. PMID: 14726863.
Table 1
Author | Local | Sex | Age (yr) | Surface | Size (cm) | Evolution (mo) | Smoking |
---|---|---|---|---|---|---|---|
Hume et al.12, 1980 | Palatal gingiva | M | 60 | Verrucous | 0.4 | 3 | - |
Neville and Weathers13, 1980 | Palatal gingiva | M | 59 | - | 1.0 | 6 | No |
Palate lingual | F | 45 | - | 0.4 | - | - | |
Palate | M | 56 | - | - | 4 | - | |
Nowparast et al.6, 1981 | Palate | M | 24 | Papillary | 0.7 | - | - |
Palate | M | 31 | Papillary | 1.5 | - | - | |
Palate | F | 66 | Verrucous | - | - | - | |
Palate | M | 62 | Verrucous | 0.3 | - | - | |
Palate | M | 50 | Papillary | 1.2 | - | - | |
Palatal junction | F | 73 | Flat | 0.7 | - | - | |
Palate | M | 81 | Flat | 0.5 | - | - | |
Palate | F | 67 | Flat | - | - | - | |
Palate | M | 89 | Verrucous | 0.3 | - | - | |
Palate | F | 75 | Verrucous | 0.3 | - | - | |
Palate | M | 52 | Verrucous | 1.0 | - | - | |
Palate | M | 77 | Verrucous | 0.4 | - | - | |
Palate | F | 78 | Verrucous | 0.4 | - | - | |
Palate | F | 71 | Flat | 0.5 | - | - | |
Palate | F | 39 | Verrucous | 1.3 | - | - | |
Palate | F | 67 | Verrucous | 0.5 | - | - | |
Kakarantza-Angelopoulou et al.8, 1991 | Palate | M | 42 | Rough | 0.7 | “Slowly” | - |
Rhinow et al.14, 2003 | Palate | - | 46 | Granular | 2.0 | - | Yes |
Hu et al.15, 2005 | Palate | M | 48 | Verrucous | 0.3 | 48 | Yes |
Yu et al.16, 2007 | Palatal gingiva | M | 31 | Papillary | 0.5 | - | No |
Palatal gingiva | M | 39 | Verrucous | 0.7 | - | Yes | |
Cheng et al.17, 2010 | Palate | M | 22 | Rough | - | Unknown | - |
Shahrabi Farahani et al.18, 2011 | Palate | M | 45 | Granular | 0.5 | - | - |
Ryu et al.19, 2013 | Palatal gingiva | M | 37 | Verrucous/papillary | 1.5 | 12 | Yes |
Palatal gingiva | M | 35 | Verrucous/papillary | 2.5 | 1 | Yes | |
Aggarwal et al.20, 2014 | Palate | M | 46 | - | 2.0 | 36 | - |
Bhattacharyya and Islam21, 2014 | Palate | F | 44 | - | 1.0 | 2 | No |
Present case | Palate | M | 43 | Verrucous | 0.5 | 2 | Yes |